The Nigeria Centre for Disease Control (NCDC) is the national public health institute for Nigeria. It is a federal government agency under the Federal Ministry of Health (Nigeria), with its headquarters in Abuja, Federal Capital Territory.The agency’s goal is to protect Nigerians from the impact of communicable diseases through the coordination of public health preparedness, surveillance, laboratory, and response functions for all infectious diseases. The NCDC targets its activities towards the prevention and control of diseases of public health importance. This includes the preparedness, detection and response to public health emergencies, research, training and knowledge management, health promotion and other activities to protect the health of Nigerians.The NCDC serves as Nigeria’s International Health Regulations (IHR) National Focal Point and is a member of the International Association of National Public Health Institutes.
Yellow fever (YF), a severe viral hemorrhagic disease caused by a member of the Orthoflavivirus genus of the Flaviviridae family, poses a persistent public health threat despite the availability of a safe and effective vaccine. The disease disproportionately affects Africa, accounting for 90
Introduction The COVID-19 pandemic has highlighted significant disparities in vaccine uptake across sub-Saharan Africa, yet research exploring the regional and country-specific factors influencing these rates remains limited. Understanding these factors is crucial for developing targeted regional and global public health interventions to improve vaccination uptake and strengthen pandemic preparedness. This study aims to fill a critical knowledge gap by assessing the factors influencing vaccination rates across sub-Saharan Africa at the operational, systemic and socio-political levels.Methods and analysis The study will employ a comparative case study design across 12 African countries to examine context-specific factors influencing pandemic vaccine preparedness. The 12 selected countries (Angola, Botswana, Burundi, Cameroon, Côte d'Ivoire, Malawi, Namibia, Nigeria, Rwanda, Senegal, South Africa and Uganda) will be categorised by vaccination rate (high, moderate or low). The study will integrate quantitative and qualitative data to provide comprehensive insights. Quantitative data, including COVID-19, macroeconomic, health system and governance indicators, will be sourced from reputable online portals, such as the WHO, the World Bank and Our World in Data. Qualitative data will be collected through key informant interviews with experts across participating African countries, except Angola. Due to delays in obtaining ethics approval in Angola, no primary data collection including key informant interviews will be conducted in Angola unless ethics approval is obtained. Angola will therefore be included through a secondary data approach, drawing on publicly available reports, published literature and relevant case studies. All qualitative data will be analysed using thematic analysis, and quantitative data will be analysed using descriptive methods.Ethics and dissemination Ethics approval was obtained from Western University’s Health Sciences Research Ethics Board (126398) and relevant bodies in the 11 participating countries. Findings will be shared through reports to public health authorities, policy briefs and presentations at academic conferences and peer-reviewed publications.
IntroductionLassa virus (LASV) causes significant morbidity in West Africa, yet vaccine trial planning is hampered by a lack of high-resolution, community-level seroprevalence data. We aimed to characterize the fine-scale spatial and demographic heterogeneity of LASV exposure in rural Nigeria to inform site selection strategies.MethodsWe conducted a cross-sectional serosurvey across nine villages in three Nigerian states (Benue, Ebonyi, and Cross River). We recruited 1,874 individuals and tested for LASV IgG using the highly specific Panadea LASV IgG ELISA. We employed Bayesian hierarchical models to estimate seroprevalence and investigated 21 pre-specified demographic, environmental, and behavioral risk factors for association with seropositivity. Village-specific transmission dynamics were explored using Bayesian generalized additive models for age-stratified seroprevalence.ResultsThe overall model-based IgG seroprevalence was 3.2% (95% CrI: 2.5-4.0%). We observed marked fine-scale heterogeneity, with village-level estimates ranging from 0.8% to 6.5%. Age-seroprevalence curves suggested? divergent transmission dynamics, ranging from cumulative endemic exposure to recent focal outbreaks in younger cohorts. Likely constrained by low overall prevalence and high exposure ubiquity, univariable analyses detected no strong or consistent associations between seropositivity and the 21 pre-specified risk factors, including rodent consumption and agricultural practices. No significant village-wide spatial clustering of seropositive households was observed via Local Getis-Ord (Gi*).DiscussionLASV exposure in rural Nigeria is characterized by low overall prevalence punctuated by significant hyper-local variation. The lack of consistent individual-level risk factors and the divergent age-exposure profiles suggest that risk may be influenced by stochastic, localized ecological drivers or obscured by the temporal misalignment of cross-sectional surveys. Vaccine trial site selection must move beyond regional incidence data to incorporate interdisciplinary, One Health metrics including high-resolution human serosurveillance and longitudinal reservoir monitoring to identify active transmission hotspots.
Background: Cholera is a major public health challenge in Nigeria. On 09 September 2021, the Adamawa State Ministry of Health confirmed an outbreak affecting 12 local government areas (LGAs). Aim: To describe the outbreak and identify risk factors. Setting: Community-based in Adamawa State, Nigeria (30 June 2021 – 01 December 2021). Methods: We described the State cholera line list (30 June 2021 – 01 December 2021) and estimated case fatality and attack rates. We conducted an unmatched case-control study in seven LGAs, involving 66 laboratory-confirmed cases and 120 asymptomatic neighbourhood controls. We collected data on demographics, clinical history, practices and risk factors using interviewer-administered questionnaires. We executed univariate, bivariate and multivariate analyses to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Results: Of 1332 cases reported across 12 LGAs, we recorded an overall case fatality rate (CFR) of 3.6%. We recorded the highest CFR (16.7%) in Song and the attack rate (N = 239.6/100 000) in Numan. Children aged 5–14 years were most affected. The median age was 24 years for cases (range: 1–76) and 32 years for controls (range: 5–70). Males accounted for 54.5% (cases) and 53.3% (controls). Independent risk factors were age < 10 years (aOR = 9.7; 95% CI: 2.6–34.9) and consumption of street-vended noodles (aOR = 7.0; 95% CI: 1.4–34.8). Conclusion: The outbreak disproportionately affected children with unregulated food sources, contributing significantly. Public health interventions included hygiene education and chlorine distribution. Strengthening food safety regulations and sustaining hygiene promotion were recommended to mitigate future outbreaks. Contribution: The study supports Nigeria’s Cholera Control Programme in refining hygiene strategies, regulating street food safety and targeting high-risk groups, such as young children.
Objectives To assess the implementation of infection prevention and control (IPC) measures and associated factors in healthcare in low-resource settings during the COVID-19 pandemic. Design Multinational cross-sectional study. Setting The study was conducted from February to November 2022 in Côte d’Ivoire, Democratic Republic of Congo, Madagascar and Nigeria. Participants A total of 6749 healthcare workers (HCWs) at 324 healthcare facilities (HCFs) were enrolled from different levels of care and types. Primary and secondary outcomes Standardised HCW and HCF questionnaires assessed COVID-19-related exposures and IPC measures and descriptive analyses were conducted overall and by country and HCF. Partial proportional odds models were used to assess factors associated with HCW compliance to hand hygiene and mask wearing. Results Among 324 HCFs, the reported presence of IPC programmes ranged from 51.4% (n=111) at primary non-hospitals to 83.3% (n=18) at tertiary HCFs. More than half reported no patient or HCW screening (57.4%, n=186). Only 19.8% (n=64) reported handrub at point of care in every room. Among 6749 enrolled HCWs, 54.0% were working in high-risk patient care. More HCWs reported sufficient availability of masks (62.7%, n=4231) compared with respirators (28.5%, n=1926). HCW compliance with hand hygiene and mask wearing, respectively, was improved by presence of an IPC programme (OR: 1.3, 95% CI 1.2 to 1.5; OR: 1.4, 95% CI 1.2 to 1.6), IPC training received by the HCW (OR: 1.5, 95% CI 1.3 to 1.7; OR: 1.3, 95% CI 1.2 to 1.5) and availability of handrub and masks, respectively (OR: 5.9, 95% CI 4.1 to 8.4; OR: 2.3, 95% CI 2.0 to 2.7). Conclusions We conducted a large survey including HCFs across levels of care and type in urban and rural regions in sub-Saharan Africa. Critical gaps in IPC programmes and access to IPC equipment during the COVID-19 pandemic hindered HCW compliance with recommended IPC practices. To improve general infection control and pandemic preparedness in low-resource settings, continued focus on strengthening IPC programmes and ensuring access to materials/equipment is essential.